Fluorine in PDB 7ty2: Crystal Structure of SETD2 Bound to An Indole-Based Inhibitor

Enzymatic activity of Crystal Structure of SETD2 Bound to An Indole-Based Inhibitor

All present enzymatic activity of Crystal Structure of SETD2 Bound to An Indole-Based Inhibitor:
2.1.1.359;

Protein crystallography data

The structure of Crystal Structure of SETD2 Bound to An Indole-Based Inhibitor, PDB code: 7ty2 was solved by N.A.Farrow, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 41.02 / 2.44
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 48.693, 75.74, 75.923, 90, 90, 90
R / Rfree (%) 21.3 / 27

Other elements in 7ty2:

The structure of Crystal Structure of SETD2 Bound to An Indole-Based Inhibitor also contains other interesting chemical elements:

Zinc (Zn) 3 atoms

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Crystal Structure of SETD2 Bound to An Indole-Based Inhibitor (pdb code 7ty2). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Crystal Structure of SETD2 Bound to An Indole-Based Inhibitor, PDB code: 7ty2:

Fluorine binding site 1 out of 1 in 7ty2

Go back to Fluorine Binding Sites List in 7ty2
Fluorine binding site 1 out of 1 in the Crystal Structure of SETD2 Bound to An Indole-Based Inhibitor


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Crystal Structure of SETD2 Bound to An Indole-Based Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1805

b:66.2
occ:1.00
F29 A:KS61805 0.0 66.2 1.0
C22 A:KS61805 1.3 63.3 1.0
C23 A:KS61805 2.3 64.7 1.0
C21 A:KS61805 2.4 61.7 1.0
C20 A:KS61805 3.1 62.0 1.0
C8 A:SAM1804 3.4 58.3 1.0
CB A:HIS1629 3.5 65.5 1.0
CD1 A:LEU1689 3.6 74.0 1.0
N7 A:SAM1804 3.6 56.0 1.0
C24 A:KS61805 3.6 62.6 1.0
C26 A:KS61805 3.7 65.1 1.0
C5' A:SAM1804 3.9 73.7 1.0
C3' A:SAM1804 4.0 65.8 1.0
C25 A:KS61805 4.1 62.0 1.0
CD2 A:TYR1666 4.2 55.3 1.0
N A:HIS1629 4.2 67.1 1.0
N9 A:SAM1804 4.2 62.9 1.0
CG A:LEU1689 4.2 72.9 1.0
CD2 A:LEU1689 4.3 70.0 1.0
CG A:TYR1666 4.3 56.6 1.0
CB A:LEU1689 4.3 75.1 1.0
CB A:TYR1666 4.3 56.0 1.0
C19 A:KS61805 4.4 60.5 1.0
C5 A:SAM1804 4.4 61.4 1.0
CA A:HIS1629 4.4 67.5 1.0
C4' A:SAM1804 4.4 69.2 1.0
CG A:HIS1629 4.5 60.2 1.0
N27 A:KS61805 4.6 64.7 1.0
C4 A:SAM1804 4.7 61.3 1.0
O3' A:SAM1804 4.8 66.6 1.0
O4' A:SAM1804 4.8 65.5 1.0
C2' A:SAM1804 4.8 65.1 1.0
CE2 A:TYR1666 4.8 54.5 1.0
C1' A:SAM1804 4.8 64.8 1.0

Reference:

J.S.Alford, J.W.Lampe, D.Brach, R.Chesworth, K.Cosmopoulos, K.W.Duncan, S.T.Eckley, J.L.Kutok, A.Raimondi, T.V.Riera, B.Shook, C.Tang, J.Totman, N.A.Farrow. Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor For Clinical Studies. Acs Med.Chem.Lett. V. 13 1137 2022.
ISSN: ISSN 1948-5875
PubMed: 35859865
DOI: 10.1021/ACSMEDCHEMLETT.2C00167
Page generated: Wed Apr 5 01:19:09 2023

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy